Seattle Genetics, Inc. (SGEN) Wednesday reported a narrower loss for the third quarter, helped mainly by higher revenues. The company also provided an outlook for the fiscal year 2012, which are currently below analysts' expectations.
Net loss for the quarter improved to $13.7 million or $0.12 per share from $40.7 million or $0.35 per share in the same period last year.
On average, 11 analysts polled by Thomson Reuters expected the company to report a loss of $0.15 per share for the quarter. Anlaysts' estimates typically exclude special items.
Revenues totaled $33.7 million, up from $10.0 million last year. Analysts expected revenues of $52.66 million.
Looking ahead to the fiscal year 2012, the company has forecast revenues in the range of $132 million to $137 million. Analysts expect revenues of $209.03 million.
Seattle Genetics closed Wednesday's trade at $24.47, down 2.12%. Shares dropped 8.05% to $22.50, losing $1.97 in the extended trade on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.